Based on this YouTube video's total view count of 793K views and industry-standard rates, the estimated total earning is $556 - $1.58K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Stop Taking THESE 5 Medications! (2X Higher Dementia Risk) with 793,929 views, 13,846 likes, and 1,022 comments. Experience the impact of this video content that has captured audience attention.

These 5 common drugs could cause dementia. It’s time to check your medicine cabinet! Researchers who tracked hundreds of thousands of older adults found that certain everyday pills were linked to up to a 54% higher rate of dementia, with brain scans showing real shrinkage in the hippocampus, the seat of memory. But two of the five most-blamed drug classes turned out to be a statistical illusion, and knowing which is which could protect your brain, or your parent’s. This video separates the genuine hazards from the false alarms, then hands you a five-question blueprint for your doctor. Never stop a prescription medication cold turkey. Abruptly quitting sedatives or acid blockers can trigger seizures, delirium, or dangerous rebound effects. This is about a smarter conversation with your doctor or pharmacist. WHAT YOU’LL LEARN: - Which two drug classes carry biologically confirmed links to brain damage, and which two are likely false alarms - How “anticholinergic burden” quietly stacks across your medicine cabinet, and why each added point raises two-year mortality by 26% - Why the benzodiazepine dementia scare largely collapsed once researchers accounted for reverse causality - The five questions that turn a rushed appointment into a real medication review CHAPTERS: 00:00 The pills we trust blindly 02:12 How to read a scary drug headline 03:13 Reverse causality and confounding 04:26 Drug 1: OTC sleep aids and allergy pills 05:33 The Gray study: 54% higher dementia risk 06:23 Drug 2: Overactive bladder meds (65% higher risk) 07:45 Drug 3: Tricyclics and the ACB scale 08:55 How anticholinergic burden stacks 09:38 Drug 4: Sleeping pills and benzos 11:16 Drug 5: Acid reflux meds and PPIs 12:54 Why people stay on these drugs for decades 13:37 The rebound trap that locks you in 14:19 What to do: never quit cold turkey 14:43 The brown bag review and 5 questions FREQUENTLY ASKED QUESTIONS 1) Which medications are linked to a higher risk of dementia? The strongest evidence points to drugs with high anticholinergic activity: OTC sleep aids and older allergy pills (diphenhydramine, doxylamine), overactive bladder drugs (oxybutynin, tolterodine), and older tricyclics like amitriptyline. A 2015 JAMA Internal Medicine study tied heavy long-term use to a 54% higher dementia risk. 2) Do sleeping pills and acid reflux drugs cause dementia? Likely not directly. Once researchers accounted for reverse causality, the benzodiazepine link nearly vanished, and large newer studies, including genetic analyses, found no causal link between PPIs like omeprazole and dementia. Both still carry other risks worth reviewing with your doctor. 3) What is anticholinergic burden? It measures how strongly your combined medications block acetylcholine, a brain chemical essential for memory. Drugs score 0 to 3 on the ACB scale, and the scores stack, so several mild drugs add up fast. Each added point is tied to a 26% higher two-year mortality risk in older adults. 4) Should I stop taking my medication? No, not on your own. Stopping suddenly can be dangerous. Bring every pill and supplement to your doctor or pharmacist for a supervised review and a slow taper if changes are warranted. 5) What is a brown bag review? You bring every medication and supplement you take, put the bag on your doctor’s desk, and review each one: why you take it, whether you still need it, your total ACB score, safer alternatives, and a gradual taper plan. SOURCES & REFERENCES 1) Gray et al., JAMA Internal Medicine (2015), anticholinergics and incident dementia; Risacher et al., brain imaging follow-up, Indiana University 2) Coupland et al., JAMA Internal Medicine (2019), 284,000 primary care records on anticholinergic drugs 3) Gray et al., BMJ (2016), benzodiazepine use and dementia with lagged exposure 4) Mehta et al., gastroenterology study of 18,000+ adults, plus Mendelian randomization analyses on PPIs; American Geriatrics Society Beers Criteria If this helped you see your medicine cabinet differently, subscribe and share it with someone who takes daily pills for sleep, heartburn, allergies, or bladder control. ABOUT THIS CHANNEL I’m Neal K. Shah, a Johns Hopkins and NIH-funded caregiving researcher and CEO of CareYaya. I’ve helped thousands of families navigate aging, dementia, and serious illness. This channel breaks down brain health, caregiving, and healthy aging to help you protect the people you love. DISCLAIMER For educational purposes only, not medical advice. I am a researcher, not a clinician. Never start, stop, or change any medication without your doctor or pharmacist. #Dementia #BrainHealth #Medications

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.